Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study

被引：0
|
作者：
Hadden, R. [1 ]
Andersen, H. [2 ]
Bril, V. [3 ]
Basta, I. [4 ]
Rejdak, K. [5 ]
Djordjevic, G. [6 ]
Greco, E. [7 ]
Hasan, S. [7 ]
French, J. [7 ]
Yel, L. [7 ]
Ay, H. [7 ]
机构：
[1] Kings Coll Hosp London, Dept Neurol, London, England
[2] Aarhus Univ, Aarhus, Denmark
[3] Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada
[4] Univ Belgrade, Univ Clin Ctr Serbia, Neurol Clin, Fac Med, Belgrade, Serbia
[5] Med Univ Lublin, Dept Neurol, Lublin, Poland
[6] Univ Clin Ctr Nis, Neurol Clin, Nish, Serbia
[7] Takeda Dev Ctr Amer Inc, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-244
引用
收藏
页码：286 / 286
页数：1
相关论文
共 50 条
  • [21] SUBCUTANEOUS IMMUNOGLOBULIN IN CIDP AND MMN: A DIFFERENT LONG-TERM CLINICAL RESPONSE?
    Merola, A.
    Cocito, D.
    Romagnolo, A.
    Peci, E.
    Toscano, A.
    Mazzeo, A.
    Gentile, L.
    Russo, M.
    Fazio, R.
    Filosto, M.
    Siciliano, G.
    Schirinzi, E.
    Lopiano, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 : S19 - S20
  • [22] Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?
    Cocito, Dario
    Merola, Aristide
    Romagnolo, Alberto
    Peci, Erdita
    Toscano, Antonio
    Mazzeo, Anna
    Gentile, Luca
    Russo, Massimo
    Fazio, Raffaella
    Filosto, Massimiliano
    Siciliano, Gabriele
    Schirinzi, Erica
    Nobile-Orazio, Eduardo
    Lopiano, Leonardo
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (07): : 791 - U136
  • [23] SUBCUTANEOUS IMMUNOGLOBULIN IN CIDP AND MMN: A DIFFERENT LONG-TERM CLINICAL RESPONSE?
    Peci, E.
    Merola, A.
    Romagnolo, A.
    Toscano, A.
    Mazzeo, A.
    Gentile, L.
    Russo, M.
    Fazio, R.
    Filosto, M.
    Siciliano, G.
    Schirinzi, E.
    Nobile-Orazio, E.
    Lopiano, V
    Cocito, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 208 - 209
  • [24] LONG-TERM TOLERABILITY AND SAFETY OF FACILITATED-SUBCUTANEOUS INFUSION OF HUMAN IMMUNOGLOBULIN G, 10%, AND RECOMBINANT HUMAN HYALURONIDASE: A PHASE 3 EXTENSION STUDY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
    Melamed, Isaac
    Wasserman, Richard L.
    Stein, Mark
    Rubinstein, Arye
    Puck, Jennifer
    Gupta, Sudhir
    Engl, Werner
    Leibl, Heinz
    Yel, Leman
    Schiff, Richard I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 727 - 728
  • [25] Phase 3 Study of Facilitated Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Interim Analysis of Immunogenicity
    Hasan, Shabbir
    Ay, Hakan
    Duff, Kimberly
    Chavan, Shailesh
    NEUROLOGY, 2021, 96 (15)
  • [26] Mechanism of action and long-term tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin (IGHy) in primary immunodeficiency diseases
    Sehinovych, Ihor
    Melamed, Isaac
    Gupta, Sudhir
    Sehinovych, Ihor
    Hermann, Corinna
    Engl, Werner
    McCoy, Barbara
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 288 - 289
  • [27] Long-Term Safety, Efficacy, and Tolerability of Subcutaneous Human Immunoglobulin 16.5% in Patients with Primary Immunodeficiencies
    Gupta, Sudhir
    Kobayashi, Roger
    Melamed, Isaac
    Rehman, Syed
    Kobayashi, Ai
    Mandujano, jose-Fernando
    Geng, Bob
    Ritchie, Bruce
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB76 - AB76
  • [28] Long-term safety of facilitated subcutaneous immunoglobulin 10% treatment in patients with primary immunodeficiency diseases: final analysis from a post-authorization safety study conducted in the USA
    Rubinstein, Arye
    Mabudian, Mohsen
    McNeil, Donald
    Patel, Niraj
    Wasserman, Richard
    Gupta, Sudhir
    Carrasco, Paz
    Nagy, Andras
    Yel, Leman
    CLINICAL IMMUNOLOGY, 2023, 250 : 36 - 37
  • [29] Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term real-world evidence study
    Manetti, Luca
    Deutschbein, Timo
    Schopohl, Jochen
    Yuen, Kevin C. J.
    Roughton, Michael
    Kriemler-Krahn, Ulrike
    Tauchmanova, Libuse
    Maamari, Ricardo
    Giordano, Carla
    PITUITARY, 2019, 22 (05) : 542 - 551
  • [30] Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study
    Luca Manetti
    Timo Deutschbein
    Jochen Schopohl
    Kevin C. J. Yuen
    Michael Roughton
    Ulrike Kriemler-Krahn
    Libuse Tauchmanova
    Ricardo Maamari
    Carla Giordano
    Pituitary, 2019, 22 : 542 - 551
12345